Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update
Biotechnology August 26, 2021
Ryan Allway August 26th, 2021 PETACH TIKVA, Israel, August 26, 2021–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended June 30, 2021. Corporate... Read more
BioHarvest Sciences Inc. Demonstrates Industry Leading Sustainability Credentials With Inaugural Environmental Sustainability Report
Biotechnology July 15, 2021
Ryan Allway July 15th, 2021 First biotechnology company engaged in the production of Cannabis biomass and cannabinoids to publish an ESG report and commit to tangible, science-based targets BioFarming manufacturing process uses 99.99% less land than traditional outdoor agriculture, while generating no direct greenhouse gases “GHG” emissions, no hazardous waste, and producing 100% biodegradable wastewater... Read more
22nd Century Announces $40 Million Common Stock Registered Direct Offering
Biotechnology June 7, 2021
Ryan Allway June 7th, 2021 Financing Provides Support to the Company’s Strategic Objectives Across All Its Plant Franchises. BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today... Read more
AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591
Biotechnology June 4, 2021
Ryan Allway June 4th, 2021 – Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients – Phase 2 Trial Underway NEW YORK, June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual... Read more
BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors
Biotechnology June 2, 2021
Ryan Allway June 2nd, 2021 Psychedelics VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has appointed Mr. Henri Sant-Cassia, co-founder of The... Read more
Ryan Allway May 6th, 2021 Psychedelics NEW YORK, May 6, 2021 /PRNewswire/ — Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric conditions, today announced the closing of a $27 million Series A round of funding led by Prime Movers Lab, an investor in breakthrough... Read more
Ryan Allway May 5th, 2021 Vancouver, BC – May 5, 2021 – Entheon Biomedical Corp. (CSE: “ENBI”; OTCQB: “ENTBF”; FSE: “1XU1”) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that it has been approved for trading on the... Read more
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
Biotechnology April 8, 2021
Ryan Allway April 8th, 2021 Psychedelics The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. VANCOUVER, BC / ACCESSWIRE / April 8, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (“Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the... Read more
Marijuana Stocks: Humble Beginnings Could Lead To Big Opportunity
Marijuana Industry NewsUncategorized August 5, 2018
For those that have been with us for a little while, you will surely remember OXIS International, which we have been covering on and off since 2014. On June 26th, 2017 we began to cover OXIS again. But a lot has happened since then. On July 17th, 2017 Oxis... Read more
- 1
- 2
